Medicine & Life Sciences
Pharmacokinetics
100%
Neoplasms
51%
Child
38%
Maximum Tolerated Dose
37%
Irinotecan
31%
4-hydroxy-N-desmethyltamoxifen
30%
Pediatrics
24%
Vorinostat
22%
Temozolomide
22%
Topotecan
18%
Appointments and Schedules
18%
gemcitabine
17%
Carboplatin
16%
Neutropenia
14%
Neuroblastoma
13%
Glioma
13%
Tamoxifen
13%
NSC 366140
13%
tanespimycin
12%
Pharmacology
11%
Half-Life
11%
Area Under Curve
11%
Leukemia
11%
Ewing's Sarcoma
11%
veliparib
11%
Drug Therapy
10%
alvocidib
10%
Pharmaceutical Preparations
10%
Therapeutics
9%
anti-IGF-1R antibody A12
9%
Idarubicin
9%
Biological Availability
8%
Breast Neoplasms
8%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8%
MLN 8237
8%
Central Nervous System Neoplasms
8%
Clinical Trials
8%
Thrombocytopenia
8%
Clinical Trials, Phase I
8%
Bortezomib
7%
Cisplatin
7%
sapanisertib
7%
Nausea
7%
Pemetrexed
7%
5-(3-methyl-1-triazeno)imidazole-4-carboxamide
7%
7-ethyl-10-hydroxycamptothecin glucuronide
7%
Heterografts
7%
batracylin
7%
Cytochrome P-450 Enzyme System
7%
idarubicinol
6%
Chemical Compounds
Pharmacokinetics
26%
Plasma
10%
Metabolite
9%
Dose
9%
Tamoxifen
8%
Pharmacological Metabolism
7%
Pemetrexed
5%
Dacarbazine
5%
Pyrrolobenzodiazepine
5%
Cyclophosphamide
5%